Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Grn
REST API REST API
Rattus norvegicus
Grn is differentially expressed in 102 experiments: 62 organism parts: extraocular muscle, kidney, ... (60 more);, 13 disease states: normal, BDL 7 days, ... (11 more);, 12 cell types 18 compound treatments 2 age (months)s and 21 other conditions.
Orthologs ENSCING00000012906 (Ciona intestinalis)   grna (Danio rerio)   Grn (Mus musculus)   GRN (Homo sapiens)   grnb (Danio rerio)   grn (Xenopus laevis)   (Compare orthologs)
InterPro Term Cys_repeat_1, Phospholipase_A2_AS, Granulin
Gene Ontology Term extracellular space, extracellular region, phospholipase A2 activity, cytokine activity, lipid catabolic process, phospholipid metabolic process, mitochondrion, blastocyst hatching, positive regulation of epithelial cell proliferation, embryo implantation
UniProt Accession P23785, Q6IN42, F1LMP7
Search EB-eye ENSRNOG00000021031
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15184, E-GEOD-19830, E-GEOD-3309, E-AFMX-7, E-GEOD-471, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-MEXP-31, E-GEOD-830, E-GEOD-2499, E-TABM-130, E-GEOD-2032, ... (6 experiments)

Factor Value U/D Experiments
Sertoli cell
3
E-MEXP-31, E-TABM-130, E-TABM-432
spermatid
1
E-TABM-130
neuron
1
E-GEOD-2499
astrocyte
1
E-GEOD-2499
fibroblast
1
E-GEOD-2032
myoctye
1
E-GEOD-2032
6 more value(s).


Disease state

studied in E-MEXP-874, E-GEOD-1872, E-MEXP-1025, E-GEOD-2470, E-GEOD-738, ... (10 experiments)

Factor Value U/D Experiments
diabetes mellitus
1
E-GEOD-2470
experimental colitis
1
E-MEXP-874
ischemia
1
E-GEOD-4105
cardiac hypertrophy
1
1
E-GEOD-738
breast carcinoma
1
E-GEOD-1872
bladder carcinoma
1
E-MTAB-104
7 more value(s).


Compound treatment

studied in E-GEOD-487, E-MEXP-1169, E-GEOD-424, E-GEOD-2303, E-MEXP-782, ... (11 experiments)

Factor Value U/D Experiments
control
8
2
E-GEOD-1978, E-GEOD-4028
none
1
2
E-MEXP-782, E-GEOD-487, E-GEOD-5282
pleiotrophin
1
E-GEOD-3394
sulphated cholecystokinin-8
1
E-MEXP-1169
butyrate
1
E-GEOD-424
diethylstilbestrol
1
E-GEOD-4028
12 more value(s).


age (months)

studied in E-GEOD-21681

Factor Value U/D Experiments
28
1
E-GEOD-21681
18
1
E-GEOD-21681


behavioral performance

studied in E-GEOD-21681

Factor Value U/D Experiments
good performers
1
E-GEOD-21681
not applicable
1
E-GEOD-21681


Biosource type
studied in E-MEXP-1069

Clinical treatment
studied in E-MEXP-976, E-GEOD-738, E-GEOD-1685, E-MTAB-104, E-GEOD-4105, ... (6 experiments)

Cohort
studied in E-GEOD-20388

compound_treatment_design
studied in E-TABM-12

Developmental stage
studied in E-GEOD-4236, E-MEXP-570, E-GEOD-903, E-GEOD-20245

Fluidics machine
studied in E-TABM-536

Genetic modification
studied in E-GEOD-6428

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-MEXP-2863, E-GEOD-7501, E-GEOD-6102, E-GEOD-1567, E-GEOD-20659, ... (6 experiments)

Infection
studied in E-MEXP-1656

Injury
studied in E-MEXP-671, E-GEOD-2599, E-GEOD-1371, E-GEOD-1685

Material type
studied in E-GEOD-4192, E-GEOD-467, E-MEXP-2527

Phenotype
studied in E-MIMR-541

protocol
studied in E-GEOD-20895

Protocol type
studied in E-MEXP-1421, E-GEOD-691, E-MEXP-532, E-MEXP-1565

Replicate
studied in E-GEOD-4192

Strain or line
studied in E-TABM-197, E-MTAB-322, E-TABM-457, E-GEOD-952, E-TABM-458, ... (8 experiments)

Temperature
studied in E-MEXP-1069

Test result
studied in E-GEOD-4745

Treatment
studied in E-GEOD-16981

Processing time: 0.301 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM